10 research outputs found

    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors - Fig 2

    Full text link
    <p><b>A</b>) Left Panel: variants obtained from exome sequencing of tumor samples from Her2-enriched Breast Cancer (HER2+ BRC) patients. Right Panel: Variants identified as potential drivers. <b>B)</b> Left Panel: variants obtained from exome sequencing of tumor samples from ER positive Breast Cancer (ER+ BRC) patients. Right Panel: Variants identified as potential drivers. Color codes are as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0194790#pone.0194790.g001" target="_blank">Fig 1</a>.</p

    Left Panel: variants obtained from exome sequencing of tumor samples from Triple Negative Breast Cancer (TNBC) patients.

    Full text link
    <p>Genes were grouped based on relevant biological activities/pathways. Right Panel: Variants identified as potential drivers (red: high-confidence drivers; gold: lower confidence drivers. Inset: Color coding scheme for types of mutations (mis-sense, termination, splice site, in-frame deletion), confidence of driver likelihood (high-confidence, lower confidence). Asterisks indicate mutations present in the COSMIC (<u>C</u>atalogue <u>o</u>f <u>S</u>omatic <u>M</u>utations in <u>C</u>ancer) database. The same coding scheme is used in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0194790#pone.0194790.g002" target="_blank">2</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0194790#pone.0194790.g005" target="_blank">5</a>.</p

    Absolute numbers of previously described and putative drivers identified in this study in different tumor types.

    Full text link
    <p>Inset: color coding reflecting tumor types. Abbreviations: TNBC (Triple Negative Breast Cancer), HER2+BC (Her2-enriched Breast Cancers), ER+BC (ER-positive Breast Cancer), CRC (Colorectal Cancer), LUAD (Lung Adenocarcinoma), LUSC (Lung Squamous Cell Carcinoma), SCC (Squamous Cell Carcinoma), SRC (Soft Tissue Sarcoma), NET (Neuroendocrine Tumor), TC (Thymic Carcinoma), GC (Gastric Cancer), SIGRCA/KRUK (Signet Ring Adenocarcinoma/Krukenberg Cell Tumor), CUPO (Carcinoma of Unknown Primary Origin).</p

    Previously described and putative drivers identified in this study grouped by functional classes or biological pathways.

    Full text link
    <p>Pathway or functional class assignment was based on Gene Ontology supplemented by individual PathCards searches (<a href="http://pathcards.genecards.org/" target="_blank">http://pathcards.genecards.org/</a>) for each gene. Inset: color coding reflecting tumor types. Abbreviations: TNBC (Triple Negative Breast Cancer), HER2+BC (Her2-enriched Breast Cancers), ER+BC (ER-positive Breast Cancer), CRC (Colorectal Cancer), LUAD (Lung Adenocarcinoma), LUSC (Lung Squamous Cell Carcinoma), SCC (Squamous Cell Carcinoma), SRC (Soft Tissue Sarcoma), NET (Neuroendocrine Tumor), TC (Thymic Carcinoma), GC (Gastric Cancer), SIGRCA/KRUK (Signet Ring Adenocarcinoma/Krukenberg Cell Tumor), CUPO (Carcinoma of Unknown Primary Origin).</p

    Left Panel: variants obtained from exome sequencing of tumor samples from Colorectal Cancer (CRC) patients.

    Full text link
    <p>Right Panel: Variants identified as potential drivers. Color codes are as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0194790#pone.0194790.g001" target="_blank">Fig 1</a>.</p
    corecore